464 related articles for article (PubMed ID: 36656015)
1. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
[TBL] [Abstract][Full Text] [Related]
2. Mucosal gene expression in response to SARS-CoV-2 is associated with early viral load.
Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
bioRxiv; 2022 Aug; ():. PubMed ID: 36052371
[TBL] [Abstract][Full Text] [Related]
3. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
[TBL] [Abstract][Full Text] [Related]
5. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
[TBL] [Abstract][Full Text] [Related]
6. High SARS-CoV-2 Viral Load and Low CCL5 Expression Levels in the Upper Respiratory Tract Are Associated With COVID-19 Severity.
Pérez-García F; Martin-Vicente M; Rojas-García RL; Castilla-García L; Muñoz-Gomez MJ; Hervás Fernández I; González Ventosa V; Vidal-Alcántara EJ; Cuadros-González J; Bermejo-Martin JF; Resino S; Martínez I
J Infect Dis; 2022 Mar; 225(6):977-982. PubMed ID: 34910814
[TBL] [Abstract][Full Text] [Related]
7. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
Ziegler CGK; Miao VN; Owings AH; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Christian T; Parker A; Sindel CB; Burger MW; Pride Y; Hasan M; Abraham GE; Senitko M; Robinson TO; Shalek AK; Glover SC; Horwitz BH; Ordovas-Montanes J
Cell; 2021 Sep; 184(18):4713-4733.e22. PubMed ID: 34352228
[TBL] [Abstract][Full Text] [Related]
8. Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.
Koch CM; Prigge AD; Anekalla KR; Shukla A; Do Umehara HC; Setar L; Chavez J; Abdala-Valencia H; Politanska Y; Markov NS; Hahn GR; Heald-Sargent T; Sanchez-Pinto LN; Muller WJ; Singer BD; Misharin AV; Ridge KM; Coates BM
Am J Respir Cell Mol Biol; 2022 Feb; 66(2):206-222. PubMed ID: 34731594
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
Zhang C; Feng YG; Tam C; Wang N; Feng Y
Front Immunol; 2021; 12():733171. PubMed ID: 34880855
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
[TBL] [Abstract][Full Text] [Related]
12. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
Moradi Marjaneh M; Challenger JD; Salas A; Gómez-Carballa A; Sivananthan A; Rivero-Calle I; Barbeito-Castiñeiras G; Foo CY; Wu Y; Liew F; Jackson HR; Habgood-Coote D; D'Souza G; Nichols SJ; Wright VJ; Levin M; Kaforou M; Thwaites RS; Okell LC; Martinón-Torres F; Cunnington AJ; ;
J Infect; 2023 Dec; 87(6):538-550. PubMed ID: 37863321
[TBL] [Abstract][Full Text] [Related]
13. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
[TBL] [Abstract][Full Text] [Related]
14. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
[TBL] [Abstract][Full Text] [Related]
15. Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure.
Nagaoka K; Kawasuji H; Murai Y; Kaneda M; Ueno A; Miyajima Y; Fukui Y; Morinaga Y; Yamamoto Y
Front Immunol; 2022; 13():844304. PubMed ID: 35237279
[TBL] [Abstract][Full Text] [Related]
16. Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Smith N; Goncalves P; Charbit B; Grzelak L; Beretta M; Planchais C; Bruel T; Rouilly V; Bondet V; Hadjadj J; Yatim N; Pere H; Merkling SH; Ghozlane A; Kernéis S; Rieux-Laucat F; Terrier B; Schwartz O; Mouquet H; Duffy D; Di Santo JP
Nat Immunol; 2021 Nov; 22(11):1428-1439. PubMed ID: 34471264
[TBL] [Abstract][Full Text] [Related]
17. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients.
Rouchka EC; Chariker JH; Alejandro B; Adcock RS; Singhal R; Ramirez J; Palmer KE; Lasnik AB; Carrico R; Arnold FW; Furmanek S; Zhang M; Wolf LA; Waigel S; Zacharias W; Bordon J; Chung D
Sci Rep; 2021 Aug; 11(1):15715. PubMed ID: 34344959
[TBL] [Abstract][Full Text] [Related]
18. Natural mucosal barriers and COVID-19 in children.
Pierce CA; Sy S; Galen B; Goldstein DY; Orner E; Keller MJ; Herold KC; Herold BC
JCI Insight; 2021 May; 6(9):. PubMed ID: 33822777
[TBL] [Abstract][Full Text] [Related]
19. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
20. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
